Wesbanco Bank Inc Pfizer Inc Transaction History

Wesbanco Bank Inc

$2.89 Billion
Q3 2024

A detailed history of Wesbanco Bank Inc transactions in Pfizer Inc stock. As of the latest transaction made, Wesbanco Bank Inc holds 249,261 shares of PFE stock, worth $6.67 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

249,261

Previous 251,945 1.07%

Holding current value

$6.67 Million

Previous $7.05 Million 2.33%

% of portfolio

0.25%

Previous 0.27%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$27.7 - $31.39 $74,346 - $84,250	-2,684 Reduced 1.07%	249,261 $7.21 Million
Q2 2024 Jul 11, 2024	BUY	$25.26 - $29.6 $57,213 - $67,044	2,265 Added 0.91%	251,945 $7.05 Million
Q1 2024 Apr 23, 2024	BUY	$25.89 - $29.73 $1.38 Million - $1.58 Million	53,190 Added 27.07%	249,680 $6.93 Million
Q4 2023 Feb 16, 2024	SELL	$26.13 - $33.94 $1.79 Million - $2.33 Million	-68,625 Reduced 25.88%	196,490 $5.66 Million
Q3 2023 Dec 11, 2023	SELL	$32.09 - $37.51 $342,913 - $400,831	-10,686 Reduced 3.87%	265,115 $8.79 Million
Q2 2023 Jul 13, 2023	BUY	$36.12 - $41.79 $311,751 - $360,689	8,631 Added 3.23%	275,801 $10.1 Million
Q1 2023 Apr 21, 2023	SELL	$39.39 - $51.28 $32,339 - $42,100	-821 Reduced 0.31%	267,170 $10.9 Million
Q4 2022 Jan 18, 2023	BUY	$41.75 - $54.5 $2.46 Million - $3.21 Million	58,967 Added 28.21%	267,991 $13.7 Million
Q3 2022 Oct 13, 2022	SELL	$43.76 - $53.42 $3.78 Million - $4.61 Million	-86,287 Reduced 29.22%	209,024 $9.15 Million
Q2 2022 Jul 18, 2022	SELL	$46.53 - $55.17 $39,317 - $46,618	-845 Reduced 0.29%	295,311 $15.5 Million
Q1 2022 Apr 25, 2022	SELL	$45.75 - $56.69 $112,636 - $139,570	-2,462 Reduced 0.82%	296,156 $15.3 Million
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $835,779 - $1.24 Million	-20,227 Reduced 6.34%	298,618 $17.6 Million
Q3 2021 Oct 12, 2021	SELL	$39.25 - $50.42 $112,765 - $144,856	-2,873 Reduced 0.89%	318,845 $13.7 Million
Q2 2021 Aug 09, 2021	SELL	$35.91 - $40.68 $184,649 - $209,176	-5,142 Reduced 1.57%	321,718 $12.6 Million
Q1 2021 May 06, 2021	SELL	$33.49 - $37.77 $208,408 - $235,042	-6,223 Reduced 1.87%	326,860 $11.8 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $18,764 - $22,014	591 Added 0.18%	333,083 $12.2 Million
Q2 2020 Jul 14, 2020	SELL	$30.12 - $36.54 $218,098 - $264,586	-7,241 Reduced 2.13%	332,492 $10.9 Million
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $34,733 - $49,626	-1,285 Reduced 0.38%	339,733 $11.1 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $14,846 - $16,849	451 Added 0.13%	341,018 $13.4 Million
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $164,074 - $212,756	-5,050 Reduced 1.46%	340,567 $12.2 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $77,916 - $87,482	-2,107 Reduced 0.61%	345,617 $15 Million
Q1 2019 May 09, 2019	BUY	$37.5 - $41.2 $362,587 - $398,362	9,669 Added 2.86%	347,724 $14.8 Million
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $38,162 - $43,509	-992 Reduced 0.29%	338,055 $14.8 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $113,061 - $137,136	-3,280 Reduced 0.96%	339,047 $14.9 Million
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $584,438 - $623,070	-17,721 Reduced 4.92%	342,327 $12.4 Million
Q1 2018 May 18, 2018	BUY	$31.91 - $37.02 $1.75 Million - $2.03 Million	54,855 Added 17.97%	360,048 $12.8 Million
Q4 2017 Feb 01, 2018	SELL	$33.26 - $35.29 $2.07 Million - $2.2 Million	-62,262 Reduced 16.94%	305,193 $11.1 Million
Q3 2017 Nov 02, 2017	SELL	$31.0 - $34.15 $13,950 - $15,367	-450 Reduced 0.12%	367,455 $13.1 Million
Q2 2017 Aug 08, 2017	BUY	N/A	367,905	367,905 $12.4 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wesbanco Bank Inc with notifications on news.

Account

Wesbanco Bank Inc Pfizer Inc Transaction History